Fujifilm announces launch of Endoscopic Submucosal Dissection device in India

Fujifilm, a leading innovator in endoscopy solutions, has announced the launch of Tracmotion, the red dot award-winning Endoscopic Submucosal Dissection (ESD) device, at Endocon 2024 in Delhi recently. Endocon, an esteemed platform for gastroenterology advancements, witnessed the unveiling of Tracmotion alongside leading-edge procedures and discussions shaping the future of endoscopic medicine.

Endocon serves as a prominent forum for medical professionals, researchers, and industry leaders to converge and exchange insights on the latest trends and innovations in gastroenterology. This year's event, held between 19 and 21 April, showcased groundbreaking procedures, including Endoscopic Ultrasound performed on the Arietta 850, alongside sessions exploring the potential of Artificial Intelligence in gastroenterology.

Endoscopic Submucosal Dissection (ESD) is a minimally invasive procedure crucial for removing precancerous and cancerous lesions in the gastrointestinal tract. It offers a targeted approach, sparing healthy tissue and enabling early intervention. Tracmotion, Fujifilm's latest innovation, marks a paradigm shift in ESD techniques.

Designed for single-operator use, its 360° rotatable retraction capability empowers precise tissue manipulation independent of the endoscope's movement. With no locking mechanisms required, Tracmotion promises enhanced flexibility and maneuverability, potentially streamlining procedures. By facilitating easier, faster interventions with improved visualisation, Tracmotion holds the promise of advancing therapeutic ESD outcomes, ultimately benefiting patient care and treatment efficacy.